Evidence-Based Treatment of Psychiatric Disorders with Comorbid Medical Illnesses: The Need for Large Simple Clinical Trials
Warren D. Taylor, MD, P. Murali Doraiswamy, M.B.,B.S., and K. Ranga R. Krishnan, M.B.,B.S
Farmacoterapias
Efectos cardiovasculares y recomendaciones en el uso de psicofarmacos
Dra. Ruby C. Castilla, Dra. Sandra R. Castilla y Dra. Wilma I. Castilla
Farmacoterapia para el tratamiento de la depresión durante la maternidad
Dra. Katherine L. Wisner
Lineamientos del concenso de expertos para el tratamiento farmacológico del trastorno bipolar: una nueva herramienta terapéutica
Dr. David A. Kahn, Dr. Gary S. Sachs, Dr. David J. Printz, Prof. Daniel Carpenter, Dr. John P. Docherty, y Mtra. Ruth Ross
ORIGINAL RESEARCH
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
By Anton B.P. Staring, C.L. Mulder, S. Priebe
Flavonoids Join the War on Cancer
By Uwe Wenzel, PhD
Fobia social: perspectivas de diagnóstico, neurobiológicas y de tratamiento
Dr. Johan Antonie den Boer y Dra. Irene Maria van Vliet
Gender and Schizophrenia
By Carla M. Canuso, MD and Gahan Pandina, PhD
Gender-Specific Differences in Depression and Treatment Response
By Susan G. Kornstein, MD, Diane M. E. Sloan, PharmD, and Michael E. Thase, MD
Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
By Philip T. Ninan, MD
Generalized Anxiety Disorder: Raising the Expectations of Treatment
By Christer Allgulander, MD, and David V. Sheehan, MD, MBA